![]() Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. | ||
Founding Date | Founding Date 1916 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Parkville, AU HQ King Of Prussia, US | Locations Heze, CN HQ |
Employees | Employees 32,698 | Employees 95920% decrease |
Valuation ($) | Valuation ($) 95.1 b | Valuation ($) 708.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $15.4b (FY, 2025) | Revenue (est.) ¥961.3m (FY, 2025) |
Cost of goods | Cost of goods $6.5b (FY, 2025) | Cost of goods ¥864.3m (FY, 2025) |
Gross profit | Gross profit $9.1b (FY, 2025) | Gross profit ¥140.3m (FY, 2025) |
Net income | Net income $3.1b (FY, 2025) | Net income (¥84.7m) (FY, 2025) |

Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View company